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ABSTRACT 
In this paper, we numerically show that the dynamics of the HIV system is sensitive to both the 
initial condition and the system parameters. These phenomena imply that the system is chaotic and 
exhibits a bifurcation behavior. To control the system, we propose to initiate an HIV therapy based on 
both the concentration of the HIV-1 viral load and the ratio of the CD4 lymphocyte population to the 
CD8 lymphocyte population. If the concentration of the HIV-1 viral load is higher than a threshold, 
then the first type of therapy will be applied. If the concentration of the HIV-1 viral load is lower than 
or equal to the threshold and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte 
population is greater than another threshold, then the second type of therapy will be applied. 
Otherwise, no therapy will be applied. The advantages of the proposed control strategy are that the 
therapy can be stopped under certain conditions, while the state variables of the overall system is 
asymptotically stable with fast convergent rate, the concentration of the controlled HIV-1 viral load is 
monotonic decreasing, as well as the positivity constraint of the system states and that of the dose 
concentration is guaranteed to be satisfied. Computer numerical simulation results are presented for 
an illustration. 
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I. INTRODUCTION 
In 2005, there were about 38.6 millions of adults and children suffering from the human 
immunodeficiency virus (HIV). The total infected population is increasing year by year [8]. There are 
about twenty medications approved by the Food and Drug Administration (FDA) of the US 
government. These medications can suppress the acquired immune deficiency syndrome (AIDS). 
It was reported in [9]-[27] that the response of the CD4 lymphocyte population, the CD8 
lymphocyte population and the HIV-1 viral load can be characterized by a first order nonlinear 
differential equation. In this paper, we numerically show that the system dynamics is sensitive to both 
the initial condition and the system parameters. This implies that the system is chaotic and exhibits a 
bifurcation behavior. Moreover, the concentrations of the CD4 lymphocyte population, the CD8 
lymphocyte population, the HIV-1 viral load and the dose are required to be non-negative and 
bounded, this implies that the positivity constraint of the system states and that of the dose 
concentration is required to be satisfied [5]. Because of the chaotic nature of the system and the 
positivity constraint, the system is very difficult to be controlled. Furthermore, the system has two 
equilibrium points and one of them is unstable [1]. This implies that a very small derivation of the 
system vectors from the equilibrium point would cause the system trajectory to diverge locally. In 
order to control the concentration of the HIV-1 viral load being exactly equal to zero within a certain 
period of time, zero boundary conditions of the controlled system are required to be satisfied. 
However, it was reported in [7] that the corresponding linearized system (linearized at the unstable 
equilibrium point) is uncontrollable, so linear control methods would usually result to the loss of 
control near the equilibrium point. 
The simplest existing strategy for controlling the HIV-1 viral load is via the P control law [1], 
[2], [4], that is the dose concentration is directly proportional to the concentration of the HIV-1 viral 
load. However, this control strategy fails to satisfy the positivity constraint and in general this control 
method does not guarantee the asymptotical stability of the system. Optimal control methods [3], [6] 
are also proposed. However, all these control methods are derived based on the corresponding 
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linearized model, in which the system will lose control when the trajectory is close to the equilibrium 
point [7]. 
As the medications have strong side effects, medical professions would prefer to initiate the 
therapy only at certain situations [7]. However, there is no standard rule for the determination of the 
time instant that the therapy initiates. Also, the corresponding dose concentration is unknown. In this 
paper, we propose to initiate the therapy based on both the concentration of the HIV-1 viral load and 
the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population. If the concentration 
of the HIV-1 viral load is higher than a threshold, then the first type of therapy will be applied. If the 
concentration of the HIV-1 viral load is lower than or equal to the threshold and the ratio of the CD4 
lymphocyte population to the CD8 lymphocyte population is greater than another threshold, then the 
second type of therapy will be applied. Otherwise, no therapy will be applied. The advantages of the 
proposed control strategy are that the therapy can be stopped under certain conditions, while the state 
variables of the overall system is asymptotically stable with fast convergent rate, the concentration of 
the controlled HIV-1 viral load is monotonic decreasing, as well as the positivity constraint of the 
system states and that of the dose concentration is guaranteed to be satisfied. 
The outline of this paper is as follows: The HIV model is reviewed in Section II. In Section III, 
the sensitivity of the initial condition and the system parameters against the system dynamics is 
simulated. The obtained results imply that the system is chaotic and exhibits a bifurcation behavior. In 
Section IV, a control strategy is proposed. Computer numerical simulation results are also presented. 
Finally, a conclusion is drawn in Section V. 
 
II. HIV MODEL 
Denote a , b , c , d , e  and f  as the system parameters, in which all are positive. Denote ( )tx , 
( )ty  and ( )tz  as the concentrations of the CD4 lymphocyte population, the CD8 lymphocyte 
population and the HIV-1 viral load, respectively. Denote 0x  and 0y  as the normal unperturbed 
International Journal of Bifurcation and Chaos 
 4
concentrations of the CD4 and CD8 lymphocyte population, respectively, in which they are also 
positive. The response of the concentrations of the CD4 lymphocyte population, the CD8 lymphocyte 
population and the HIV-1 viral load can be characterized by the following first order nonlinear 
differential equation [9]-[27]: 
 ( ) ( )( ) ( ) ( )tztbxtxxatx −−= 0& , (1a) 
 ( ) ( )( ) ( ) ( )tztdytyycty +−= 0&  (1b) 
and 
 ( ) ( ) ( ) ( )( )tfytextztz −=& . (1c) 
It can be checked easily that the equilibrium points of the system are 
 [ ]Tyx 000  (2a) 
and 
 ( ) ( )
( ) T
bfcyaedx
fyexac
bcadf
bfcyaedx
bcade
bfcyaedx ⎥⎦
⎤⎢⎣
⎡
+
−
+
+
+
+
00
000000 . (2b) 
 
III. SENSITIVITY OF INITIAL CONDITION AND SYSTEM PARAMETERS AGAINST 
SYSTEM DYNAMICS 
Figure 1a shows the state responses of the system, while Figure 1b shows the corresponding 
state trajectory, in which 25.0=a , 50=b , 25.0=c , 10=d , 01.0=e , 006.0=f , 10000 =x , 
5500 =y , ( ) 00 xx = , ( ) 00 yy =  and ( ) 03.00 =z . It can be seen from Figure 1b that the system exhibits 
a complex behavior. Figure 2 plots the Lyapunov exponents of the system at different time instants 
with the system parameters being the same as that applied in Figure 1 and with the initial condition 
being the state vectors at the corresponding time instants. It can be seen from Figure 2 that the 
Lyapunov exponent of ( )tz  is positive during the transient moment and at 15.4=t  year. Figure 3 
plots the difference of the state responses between the following two sets of initial conditions with the 
same set of system parameters applied in Figure 1: ( ) 4420 =x , ( ) 7360 =y  and ( ) 0063.00 =z , and its 
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1% increment, that is ( ) 42.4460 =x , ( ) 36.7430 =y  and ( ) 0064.00 =z . It can be seen from Figure 3 
that the difference of the state responses between the above two sets of initial conditions are very 
large even though these two sets of initial conditions are differed only by 1%. This implies that the 
system is very sensitive to the initial condition. To investigate the sensitivity of the system parameters 
against the system dynamics, since there are six system parameters in the HIV model, namely, a , b , 
c , d , e  and f , the range of the concentrations of the CD4 lymphocyte population, CD8 lymphocyte 
population and the HIV-1 viral load are plotted with respect to these system parameters. Figure 4a, 
Figure 4b and Figure 4c plot the ranges of ( )tx , ( )ty  and ( )tz  as a  varies when 50=b , 25.0=c , 
10=d , 01.0=e , 006.0=f , 10000 =x , 5500 =y , ( ) 00 xx = , ( ) 00 yy =  and ( ) 03.00 =z . Similarly, 
Figure 5 to Figure 9 plot the corresponding ranges as the parameter b  to the parameter f vary, 
respectively. From these computer numerical simulation results, we can see that the parameters d  
and e  are the most sensitive to the system dynamics. Hence, we can conclude that the system is 
chaotic and exhibits a bifurcation phenomenon. This chaotic nature of the system causes the 
formulation of the control strategy being very challenging. 
 
IV. PROPOSED CONTROL STRATEGY 
Denote ( )tU  as the dose concentration. This corresponds to the control force of the system. 
Assume that ( )tU  is applying directly to ( )tz , that is: 
( ) ( )( ) ( ) ( )tztbxtxxatx −−= 0& , (3a) 
( ) ( )( ) ( ) ( )tztdytyycty +−= 0&  (3b) 
and 
( ) ( ) ( ) ( )( ) ( )tUtfytextztz −−=& . (3c) 
Consider the following control force 
( ) ( )( ) ( )( )tfy
tztxetU
4
22
=  (4) 
and define 
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( ) ( )( )2tztV = . (5) 
It can be easily seen that ( ) 0>tV  for ( ) 0≠tz , and 
( ) ( ) ( ) ( )( )( )tfy
tfytextztz
4
2 2−−=& . (6) 
Consequently, we have 
( ) ( )( ) ( ) ( )( )( )tfy
tfytextztV
2
2 22 −−=& . (7) 
As 
( ) ( )( ) ( ) ( )tztbxtxxatx −−= 0& , (8) 
we have 
( ) ( )( )( )( ) ⎟⎠⎞⎜⎝⎛ +
⎟⎠
⎞⎜⎝
⎛ +
=
∫
∫ ∫
∞−
∞− ∞−
t
t
dbza
ddbzaax
tx
ττ
ξττξ
exp
exp0
. (9) 
Similarly, as 
( ) ( )( ) ( ) ( )tztdytyycty +−= 0& , (10) 
we have 
( ) ( )( )( )( ) ⎟⎠⎞⎜⎝⎛ −
⎟⎠
⎞⎜⎝
⎛ −
=
∫
∫ ∫
∞−
∞− ∞−
t
t
ddzc
dddzccy
ty
ττ
ξττξ
exp
exp0
. (11) 
Since a , c , 0x  and 0y  are positive, from (9) and (11), we can conclude that ( ) 0>tx  and ( ) 0>ty  
0≥∀t . By putting ( ) 0>ty  and 0>f  to (7), we can conclude that ( ) 0<tV&  0≥∀t . Since we 
assume that ( ) 00 >z , we have ( ) 0<tz&  0≥∀t , ( ) 0>tz  0≥∀t  and ( ) 0lim =+∞→ tzt . By putting 0>f , 
( ) 0>ty  and ( ) 0>tz  to (4), we have ( ) 0>tU  0≥∀t . When ( ) 0≈tz  Tt ≥∀ , where T  is a positive 
real number, from (9) and (11), we have 
( ) ( )( ) ( )( )tTaxTxxtx −−+≈ exp00  (12) 
and 
( ) ( )( ) ( )( )tTcyTyyty −−+≈ exp00  Tt ≥∀ . (13) 
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Since a  and c  are positive, we have 
( ) 0lim xtxt ≈+∞→  (14) 
and 
( ) 0lim ytyt ≈+∞→ . (15) 
Consequently, both ( )tx  and ( )ty  are bounded and converge to the corresponding equilibrium values. 
Hence, this control strategy can guarantee the asymptotical stability of the system, the monotonic 
decrement of the concentration of the HIV-1 viral load, as well as the satisfaction of the positivity 
constraint of the system states and that of the dose concentration. 
Although this control strategy guarantees that the system states will converge to the equilibrium 
point, the convergent rate is slow because ( )tV  is independent of both ( )tx  and ( )ty . Now, consider 
another control force as follows: 
( ) ( )( ) ( )( ) ( ) 3
2
01
2
0
3
2
22
424 k
bxkyty
k
dk
tfy
tztxetU +⎟⎠
⎞⎜⎝
⎛ −+=  (16) 
and define 
( ) ( )( ) ( )( ) ( )( )23202201 tzktyyktxxktV +−+−= , (17) 
where 1k  and 2k  are non-negative constants as well as 3k  is a positive constant. Obviously, the 
previous control strategy is a particular case of this control strategy. Now, we have 
( ) ( ) ( ) ( )( )( ) ( ) 3
2
01
2
0
3
2
2
424
2
k
bxkyty
k
dk
tfy
tfytextztz −⎟⎠
⎞⎜⎝
⎛ −−−−=&  (18) 
and 
( ) ( )( ) ( ) ( )( )( ) ( )( ) ( )( ) ( ) ( )
( )
22
222
2
2 202
2
0
1
2
01
2
02
22
3 ytdzkxtxtbzktxxaktyyck
tfy
tfytextzktV −⎟⎠
⎞⎜⎝
⎛ −−−−−−−−=& .(19) 
It can be checked easily that ( ) 0>tV  for ( ) ( ) ( )( ) ( )0,,,, 00 yxtztytx ≠ . Similarly, from (9) and (11), we 
have ( ) 0>tx  and ( ) 0>ty  0≥∀t . If ( ) 0>tz  0≥∀t , then ( ) 0>tU , ( ) 0<tV&  and ( ) 0<tz&  0≥∀t . 
Hence, the success of this control strategy highly depends whether ( ) 0>tz  0≥∀t  or not. However, 
in general it is not guaranteed that ( ) 0>tz  0≥∀t  is satisfied even though this control strategy could 
achieve a fast convergent rate because ( )tV  depends on both ( )tx  and ( )ty . 
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Now, consider an uncontrolled case, that is: 
( ) 0=tU . (20) 
Define 
( ) ( )( )2tztV = , (21) 
then we have 
( ) ( ) ( ) ( )( )tfytextztz −=&  (22) 
and 
( ) ( )( ) ( ) ( )( )tfytextztV −= 22& . (23) 
It can be checked easily that ( ) 0>tV  for ( ) 0≠tz . Similarly, from (9) and (11), we have ( ) 0>tx  and 
( ) 0>ty  0≥∀t . If ( ) ( ) 0<− tfytex , then ( ) 0<tV& . Since we assume that ( ) 00 >z , we have ( ) 0<tz&  
0≥∀t , ( ) 0>tz  0≥∀t  and ( ) 0lim =+∞→ tzt . Similarly, we have ( ) 0lim xtxt ≈+∞→  and ( ) 0lim ytyt ≈+∞→ . Hence, 
the success of the uncontrolled strategy highly depends whether ( ) ( ) 0<− tfytex  or not. However, in 
general it is not guaranteed that ( ) ( ) 0<− tfytex  is satisfied even though the uncontrolled strategy 
does not require patients taking medications and patients do not need to tolerate the side effects of the 
medications. 
Now, consider the following control strategy: 
Theorem 1 
Assume that ( ) ( ) ( ) 00,0,0,,,,,,,,,,, 32100 >zyxkkkyxfedcba . Denote α  as a positive constant. 
Case I: If ( ) α>tz , then 
( ) ( )( ) ( )( ) ( ) 3
2
01
2
0
3
2
22
424 k
bxkyty
k
dk
tfy
tztxetU +⎟⎠
⎞⎜⎝
⎛ −+= . 
Case II: If ( ) 0>≥ tzα  and ( ) ( ) 0≥− tfytex , then 
( ) ( )( ) ( )( )tfy
tztxetU
4
22
= . 
Case III: If ( ) 0>≥ tzα  and ( ) ( ) 0<− tfytex , then 
( ) 0=tU . 
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The overall controlled system is asymptotically stable, the concentration of the HIV-1 viral load is 
monotonic decreasing, as well as the positivity constraint of the system states and that of the dose 
concentration is guaranteed to be satisfied. 
Proof: 
Since ( ) 0<tz&  for all these three cases and ( ) 00 >z , the system can only switch from Case I to 
either Case II or Case III, but not vice versa. If ( ) α≤0z , then the system can only operate in Case II 
and Case III. If ( ) α>0z , as ( ) 0<tz& , ( )tz  is decreasing until it reaches the value α  and then switches 
to either Case II or Case III. Hence, the objective of the control strategy defined by Case I is to 
accelerate the transient response. Once the system is operating under the control strategy defined by 
either Case II or Case III, as ( ) 0<tV& , ( ) 0<tz& , ( ) 0>tx , ( ) 0>ty , ( ) 0>tz  and ( ) 0≥tU  0≥∀t  as well 
as ( ) 0lim xtxt ≈+∞→ , ( ) 0lim ytyt ≈+∞→  and ( ) 0lim =+∞→ tzt  for both Case II and Case III, the positivity constraint 
of the system states and that of the dose concentration will be satisfied, the concentration of the HIV-1 
viral load will be monotonic decreasing, as well as the asymptotical stability of the overall system 
will be guaranteed. This completes the proof. ▄ 
There are four parameters in the controlled system, namely, α , 1k , 2k  and 3k . Actually 
Theorem 1 is valid 0,,, 321 >∀ kkkα . To design the value of α , since α  is the concentration of the 
HIV-1 viral load in which the control strategy is switched from Case I to either Case II or Case III, and 
the rate of the change of the concentration of the HIV-1 viral load under the control strategy defined 
by Case I is faster than that defined by Case II and Case III, α  should be small so that the 
concentration of the HIV-1 viral load will decrease at a faster rate. However, as ( ) 0≠tz&  when 
( ) 0=tz , too small value of α  would cause a rapid change of the state trajectory near the equilibrium 
point. Consequently, patients cannot stop the therapy. To obtain a balance between these two factors, 
we choose α  to be a value equal to 59.5140% of ( )0z  in our computer numerical simulation, that is 
0.0179. For the values of 1k , 2k  and 3k , from (16), we see that ( )tU  is small if 1k  and 2k  are small 
and 3k  is large. In the practical situation, ( )tU  should be small so that the side effects of the 
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medications are negligible. However, we can see from (18) that the rate of change of the 
concentration of the HIV-1 viral load is large if 1k  and 2k  are large and 3k  is small. As a fast response 
is preferred, there is a tradeoff between the strength of the side effects and the convergent rate of the 
system. To obtain a balance between these two factors, we propose to solve the problem via an 
optimization approach as follows: 
For the control strategy defined by Case I, since 
( ) ( ) ( ) ( )( ) ( )( )( )
( ) ( ) ( ) ( )( ) ( )
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛ ++⎥⎦
⎤⎢⎣
⎡ −⎟⎠
⎞⎜⎝
⎛ −=
ty
tztxtxtztx
f
e
tyf
tztxeyty
k
dktytU &&&&
22
2
22
0
3
2 2
442
2  (24) 
and ( ) 0<tz&  0≥∀t , if ( ) 0<tx& , ( ) 0>ty&  and 
( ) ( )( ) ( )( )( )2
22
0
3
2
42
2
tyf
tztxeyty
k
dk <⎟⎠
⎞⎜⎝
⎛ −  ( ) α>∀ tz , 
then we have ( ) 0<tU&  ( ) α>∀ tz . This implies that the maximum value of ( )tU  will occur at 0=t  if 
the above conditions are satisfied. Define an acceptable bound on the dose concentration as maxU . 
Then 1k , 2k  and 3k  are designed such that ( ) maxUtU <  ( ) α>∀ tz . That is: 
( )( ) ( )
( ) ( ) max3
2
01
2
0
3
2
22
42
0
04
00 U
k
bxkyy
k
dk
fy
zxe <+⎟⎠
⎞⎜⎝
⎛ −+ . (25) 
Similarly, we define an acceptable bound on the rate of change of the concentration of the HIV-1 viral 
load and on the rate of change of ( )tV  at 0=t  as maxz&  and maxV& , respectively. From (18) and (19), we 
have 
( )
( ) ( ) ( )( ) ( ) max3
2
01
2
0
3
22
42
0020
04
0 z
k
bxkyy
k
dkfyex
fy
z &<−⎟⎠
⎞⎜⎝
⎛ −−−−  (26) 
and 
( )( )
( ) ( ) ( )( ) ( )( ) ( )( ) ( ) ( )
( )
max
2
02
2
0
1
2
01
2
02
2
2
3
2
0
2
0020202020
02
0 Vydzkxxbzkxxakyyckfyex
fy
zk &<−⎟⎠
⎞⎜⎝
⎛ −−−−−−−− .(27) 
(25)-(27), as well as 1k , 2k  and 3k  being positive, forms a linear matrix inequality constraint on  1k , 
2k  and 3k . For most of patients, maxU  should be set around 0.37. Hence, we choose maxU  accordingly. 
In order to have a fast response, maxz&  and maxV&  should be as small as possible, hence we choose maxz&  
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and maxV&  as -0.15 and -0.0095, respectively. 
Due to the tradeoff between the strength of the side effects and the convergent rate of the system, 
we formulate the following optimization problem as follows: 
Problem (P) 
( )321 ,,minkkk
 321 kkk ++ , (28a) 
subject to (25)-(27)  (28b) 
and 1k , 2k  and 3k  are positive. (28c) 
Problem P is a standard linear programming problem, many existing solvers, such as Matlab 
optimization toolbox, can be employed for solving the problem. Moreover, as this optimization 
problem is convex, the obtained solution will be globally optimal if the feasible set is nonempty. 
Figure 10 plots the controlled state responses with the system parameters and the initial 
condition being the same as those applied in Figure 1, where α , 1k , 2k  and 3k  are determined based 
on the above discussion. It can be seen from the figure that the concentration of the HIV-1 viral load is 
monotonic decreasing, the system states asymptotically converge to the equilibrium point, as well as 
the concentrations of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load are non-negative and bounded. Hence, the proposed control strategy satisfies the positivity 
constraint. Figure 11 shows the corresponding dose concentration. It can be seen from the figure that 
the maximum dose concentration within the first 4 weeks is 0.37, which satisfies the specification. 
The dose concentration is monotonic decreasing within the first 4 weeks, but it drops dramatically to 
low values after the 4th week because the system switches from the control strategy defined by Case 
I to that defined by Case II. Between the 85.7th and 219.7th weeks, the dose concentration is exactly 
equal to zero. This implies that the system switches to the control strategy defined by Case III and no 
therapy is required. After the 219.7th week, the system switches back to the control strategy defined 
by Case II, so the dose concentration is non-zero and maintains at low level. To illustrate the 
effectiveness of the control strategy defined by Case I, Figure 12 plots the controlled state responses 
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of the system switched only between Case II and Case III. Figure 13 plots the corresponding dose 
concentration with the system parameters and the initial condition being the same as those applied in 
Figure 1. It can be seen from the figure that the concentration of the HIV-1 viral load decreases slowly 
while that based on the control strategy defined by Case I drops to the value equal to α  quickly (at 
the 4th week). 
 
V. CONCLUSIONS 
In this paper, we suggest to initiate the therapy based on both the concentration of the HIV-1 
viral load and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population. If the 
concentration of the HIV-1 viral load is higher than a threshold, then the first type of therapy will be 
applied. If the concentration of the HIV-1 viral load is lower than or equal to the threshold and the 
ratio of the CD4 lymphocyte population to the CD8 lymphocyte population is greater than another 
threshold, then the second type of therapy will be applied. Otherwise, no therapy will be applied. The 
advantages of the proposed control strategy are that the therapy can be stopped under certain 
conditions, while the state variables of the overall system is asymptotically stable with fast 
convergent rate, the concentration of the controlled HIV-1 viral load is monotonic decreasing, as well 
as the positivity constraint of the system states and that of the dose concentration is guaranteed to be 
satisfied. 
 
ACKNOWLEDGEMENT 
The work obtained in this paper was supported by a research grant from Queen Mary, 
University of London. 
 
REFERENCES 
[1] Fernando Menezes Campello de Souza, “Modeling the dynamics of HIV-1 and CD4 and CD8 
lymphocytes,” IEEE Engineering in Medicine and Biology, vol. 18, no. 1, pp. 21-24, 1999. 
International Journal of Bifurcation and Chaos 
 13
[2] Michael E. Brandt and Guanrong Chen, “Feedback control of a biodynamical model of HIV-1,” 
IEEE Transactions on Biomedical Engineering, vol. 48, no. 7, pp. 754-759, 2001. 
[3] Ji Hyun Ko, Won Hee Kim and Chung Choo Chung, “Optimized structured treatment 
interruption for HIV therapy and its performance analysis on controllability,” IEEE Transactions 
on Biomedical Engineering, vol. 53, no. 3, pp. 380-386, 2006. 
[4] Ian K. Craig and Xiaohua Xia, “Can HIV/AIDS be controlled? Applying control engineering 
concepts outside traditional fields,” IEEE Control Systems Magazine, vol. 25, no. 1, pp. 80-83, 
2005. 
[5] Shuzhi Sam Ge, Zhiling Tian and Tong Heng Lee, “Nonlinear control of a dynamic model of 
HIV-1,” IEEE Transactions on Biomedical Engineering, vol. 52, no. 3, pp. 353-361, 2005. 
[6] Dhiraj Arora, Mikhail Skliar and Robert B. Roemer, “Minimum-time thermal dose control of 
thermal therapies,” IEEE Transactions on Biomedical Engineering, vol. 52, no. 2, pp. 191-200, 
2005. 
[7] Annah M. Jeffrey, Xiaohua Xia and Ian K. Craig, “When to initiate HIV therapy: a control 
theoretic approach,” IEEE Transactions on Biomedical Engineering, vol. 50, no. 11, pp. 
1213-1220, 2003. 
[8] Ian K. Craig, Xiaohua Xia and Juliana W. Venter, “Introducing HIV/AIDS education into the 
electrical engineering curriculum at the university of Pretoria,” IEEE Transactions on Education, 
vol. 47, no. 1, pp. 65-73, 2004. 
[9] R.A. Filter, X. Xia and C. M. Gray, “Dynamic HIV/AIDS parameter estimation with application 
to a vaccine readiness study in Southern Africa,” IEEE Transactions on Biomedical Engineering, 
vol. 52, no. 5, pp. 784-791, 2005. 
[10] X. Xia and C. H. Moog, “Identifiability of nonlinear systems with application to HIV/AIDS 
models,” IEEE Transactions on Automatic Control, vol. 48, no. 2, pp. 330-336, 2003. 
[11] B. J. Hammond, “Quantitative study of the control of HIV-1 gene expression,” Journal of 
Theoretical Biology, vol. 163, pp. 199-221, 1993. 
International Journal of Bifurcation and Chaos 
 14
[12] Lawrence M. Wein, Stefanos A. Zenios and Martin A. Nowak, “Dynamic multidrug therapies for 
HIV: a control theoretic approach,” Journal of Theoretical Biology, vol. 185, pp. 15-29, 1997. 
[13] Rob J. de Boer and Alan S. Perelson, “Target cell limited and immune control models of HIV 
infection: a compression,” Journal of Theoretical Biology, vol. 190, pp. 201-214, 1998. 
[14] Lawrence M. Wein, Rebecca M. D’Amato and Alan S. Perelson, “Mathematical analysis of 
antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads,” Journal of 
Theoretical Biology, vol. 192, pp. 81-98, 1998. 
[15] Narendra M. Dixit and Alan S. Perelson, “Complex patterns of viral load decay under 
antiretroviral therapy: influence of pharmacokinetics and intracellular delay,” Journal of 
Theoretical Biology, vol. 226, pp. 95-109, 2004. 
[16] Max A. Strfford, Lawerence Corey, Yunzhen Cao, Eric S. Daar, David D. Ho and Alan S. 
Perelson, “Modeling plasma virus concentration during primary HIV infection,” Journal of 
Theoretical Biology, vol. 203, pp. 285-301, 2000. 
[17] Michael A. Fishman and Alan S. Perelson, “Th1/Th2 cross regulation,” Journal of Theoretical 
Biology, vol. 170, pp. 25-56, 1994. 
[18] Paulina Essunger and Alan S. Perelson, “Modeling HIV infection of CD4 P+P T-cell 
subpopulations,” Journal of Theoretical Biology, vol. 170, pp. 367-391, 1994. 
[19] Richard M. Berry and Martin A. Nowak, “Defective escape mutants of HIV,” Journal of 
Theoretical Biology, vol. 171, pp. 387-395, 1994. 
[20] Marc Lipsitch and Martin A. Nowak, “The evolution of virulence in sexually transmitted 
HIV/AIDS,” Journal of Theoretical Biology, vol. 174, pp. 427-440, 1995. 
[21] Martin A. Nowak, Robert M. May and Karl Sigmund, “Immune responses against multiple 
epitopes,” Journal of Theoretical Biology, vol. 175, pp. 352-353, 1995. 
[22] Franck Courchamp, Dominique Pontier, Michel Langlais and Marc Artois, “Population 
dynamics of feline immunodeficiency virus within cat populations,” Journal of Theoretical 
Biology, vol. 175, pp. 553-560, 1995. 
International Journal of Bifurcation and Chaos 
 15
[23] Yoh Iwasa, Franziska Michor and Martin A. Nowak, “Virus evolution within patients increases 
pathogenicity,” Journal of Theoretical Biology, vol. 232, pp. 17-26, 2005. 
[24] Martin A. Nowak, Sebastian Bonhoeffer, George M. Shaw and Robert M. May, “Anti-viral drug 
treatment: dynamics of resistance in free virus and infected cell populations,” Journal of 
Theoretical Biology, vol. 184, pp. 203-217, 1997. 
[25] Dominik Wodarz, Alun L. Lloyd, Vincent A. A. Jansen and Martin A. Nowak, “Dynamics of 
macrophage and T cell infection by HIV,” Journal of Theoretical Biology, vol. 196, pp. 101-113, 
1999. 
[26] Michael A. Gilchrist, Daniel Coombs and Alan S. Perelson, “Optimizing within-host viral 
fitness: infected cell lifespan and virion production rate,” Journal of Theoretical Biology, vol. 
229, pp. 281-288, 2004. 
[27] R. M. Jafelice, L. C. Barros, R. C. Bassanezi F. Gomide, “Fuzzy set-based model to compute the 
life expectancy of HIV infected populations,” IEEE Annual Meeting of the Fuzzy Information 
Processing, NAFIPS, vol. 1, pp. 314-318, 27-30 June 2004. 
0 2 4 6 8 10 12 14 16 18 20
0
100
200
300
400
500
600
700
800
900
1000
Time t (years)
C
el
l p
op
ul
at
io
ns
 (/
m
m3
) a
nd
 v
ira
l l
oa
d 
(C
op
ie
s 
x 
10
00
0/
m
l) 
Responses of HIV system (no drugs)
CD4 cells
CD8 cells
Viral load
 
Figure 1a. State responses of the system. 
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Figure 1b. The state trajectory of the system. 
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Figure 2. Lyapunov exponents of the system. 
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Figure 3. Difference of the responses of the CD4 lymphocyte population, the CD8 lymphocyte 
population and the HIV-1 viral load at different initial conditions. 
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Figure 4. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter a  varies. 
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Figure 5. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter b  varies. 
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Figure 6. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter c  varies. 
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Figure 7. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter d  varies. 
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Figure 8. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter e  varies. 
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Figure 9. Ranges of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 
viral load as parameter f  varies. 
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Figure 10. State responses of the overall controlled system. 
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Figure 11. Dose concentration. 
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Figure 12. State responses of the overall controlled system. 
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Figure 13. Dose concentration. 
